PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection

Emerging strategies that center upon the mammalian target of rapamycin (mTOR) signaling for neurodegenerative disorders may bring effective treatment for a number of difficult disease entities. Here we show that erythropoietin (EPO), a novel agent for nervous system disorders, prevents apoptotic SH-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chong, Zhao Zhong, Shang, Yan Chen, Wang, Shaohui, Maiese, Kenneth
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2012
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3445503/
https://ncbi.nlm.nih.gov/pubmed/23029019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0045456
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller